000 | 01557 a2200433 4500 | ||
---|---|---|---|
005 | 20250516160839.0 | ||
264 | 0 | _c20140522 | |
008 | 201405s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.1070 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYi, Yong Weon | |
245 | 0 | 0 |
_aTargeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cells. _h[electronic resource] |
260 |
_bOncotarget _cJul 2013 |
||
300 |
_a984-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetylation _xdrug effects |
650 | 0 | 4 |
_aApoptosis _xphysiology |
650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aChalcones _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
650 | 0 | 4 |
_aSirtuin 1 _xgenetics |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
700 | 1 | _aKang, Hyo Jin | |
700 | 1 | _aKim, Hee Jeong | |
700 | 1 | _aKong, Yali | |
700 | 1 | _aBrown, Milton L | |
700 | 1 | _aBae, Insoo | |
773 | 0 |
_tOncotarget _gvol. 4 _gno. 7 _gp. 984-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.1070 _zAvailable from publisher's website |
999 |
_c22910539 _d22910539 |